Compare SDHC & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDHC | CSBR |
|---|---|---|
| Founded | 2008 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 83.5M |
| IPO Year | 2023 | 2015 |
| Metric | SDHC | CSBR |
|---|---|---|
| Price | $12.26 | $5.87 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.60 | N/A |
| AVG Volume (30 Days) | ★ 79.2K | 5.9K |
| Earning Date | 04-29-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $971,116,000.00 | $2,900,000.00 |
| Revenue This Year | $4.21 | $4.84 |
| Revenue Next Year | $11.07 | $11.51 |
| P/E Ratio | $199.33 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.72 | $5.50 |
| 52 Week High | $23.50 | $9.63 |
| Indicator | SDHC | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 47.37 |
| Support Level | $11.18 | $5.60 |
| Resistance Level | $15.45 | $6.31 |
| Average True Range (ATR) | 0.63 | 0.25 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 62.75 | 25.39 |
Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.